Prospective Cohort of Patients With Intracerebral Hemorrhage
NCT ID: NCT06670456
Last Updated: 2024-11-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
3000 participants
OBSERVATIONAL
2023-11-06
2028-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Outcomes Following Primary Intracerebral Hemorrhage
NCT06548737
Prospective Cohort Study of Intracerebral Hemorrhage
NCT04707105
Interventional Study for Detection of Prognosis of Blood Based Biomarkers in Intracerebral Hemorrhage
NCT06745037
Retrospective Cohort Study of Intracerebral Hemorrhage
NCT04803292
A Cohort Study of Patients With Intracranial Hemorrhage
NCT05760950
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Underwent no surgical intervention;
Exclusion Criteria
* Pre-stroke life expectancy \< 1 year for severe comorbidities (e.g., Progressive malignant tumor, severe chronic heart failure \[NYHA: III-IV\], severe chronic obstructive pulmonary disease \[III-IV\], chronic kidney disease requiring hemodialysis)
* Severe dependency or incorporation to interview (e.g., pre-stroke mRS\>3, severe dementia, intractable mental disease)
* Unsuitable for inclusion in the study in the opinion of the investigator
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fuzhou University
OTHER
Fujian Medical University
OTHER
National Institute of Hospital Administration (China)
UNKNOWN
De-zhi Kang
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
De-zhi Kang
Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
De-zhi Kang, MD
Role: PRINCIPAL_INVESTIGATOR
First Affiliated Hospital of Fujian Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Anxi County Hospital
Quanzhou, Fujian, China
Jinjiang Municipal Hospital
Quanzhou, Fujian, China
The Second Affiliated lospital of Xiamen Medical College
Xiamen, Fujian, China
Zhangzhou Municipal Hospital
Zhangzhou, Fujian, China
Liaocheng People's Hospital
Liaocheng, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jian-cai Chen
Role: primary
Nao-nan Weng
Role: backup
Xie-li Guo
Role: primary
Zhen Qi
Role: backup
Jian-wu Long
Role: primary
Chun Luo
Role: backup
Wei-wei Wang
Role: primary
Zhang Guo
Role: backup
Wei-dong Liu
Role: primary
Han-yu Sun
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022ZD01003
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.